⌘K

Login Start Free

Home/Insiders/Lees-Rolfe Garth

LG

SEC Insider//CIK 0002017374

Lees-Rolfe Garth

CIK 00020173742 companiesLEXINGTON, MA

Transactions

8

Companies

2

Filings

3

CIK

0002017374

Recent Transactions

8 trades

Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21+5,834→ 5,834 total
Disposition to Issuer
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21−5,834→ 0 total
Disposition to Issuer
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21−90,000→ 0 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21+90,000→ 90,000 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-03+235,383→ 235,383 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-03+432,853→ 432,853 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-03+470,861→ 470,861 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (right to buy)
2024-04-01+90,000→ 90,000 total

Companies

2

Recent Filings

3

Address

1 CRANBERRY HILL, SUITE 200

LEXINGTON, MA, 02421

View on SEC.gov